A randomised placebo-controlled Phase III : low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial).: low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial). (2017)